CHIA-HUNG LINChang, C-KC-KChangShih, C-WC-WShihHUNG-YUAN LIChen, K-YK-YChenWEI-SHIUNG YANGKEH-SUNG TSAICHIH-YUAN WANGSHYANG-RONG SHIH2023-02-142023-02-142019-110937-941Xhttps://scholars.lib.ntu.edu.tw/handle/123456789/628063This study investigated the alterations of mineral metabolism in patients with Graves' disease (GD) who achieved euthyroidism. They had higher fibroblast growth factor 23 (FGF23) and phosphorus as compared with healthy subjects. Serum FGF23 was negatively correlated with serum phosphorus. These indicated abnormal mineral metabolism even after 1.6 years of euthyroid status.enFibroblast growth factor 23; Graves’ disease; Osteoporosis; Phosphorusjournal article10.1007/s00198-019-05116-1313849562-s2.0-85070220714WOS:000501843100014https://api.elsevier.com/content/abstract/scopus_id/85070220714